Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT03347292 |
| Title | Regorafenib Plus Pembrolizumab in First Line Systemic Treatment of HCC |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Bayer |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | DEU |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| USC Norris Hospital and Clinics | Los Angeles | California | 90033 | United States | Details | |
| University of Florida Health Sciences Center | Gainesville | Florida | 32610-0286 | United States | Details | |
| H. Lee Moffitt Cancer Center & Research Institute | Tampa | Florida | 33612 | United States | Details | |
| Mount Sinai Medical Center | New York | New York | 10029 | United States | Details | |
| Seattle Cancer Care Alliance | Seattle | Washington | 98109-1023 | United States | Details | |
| Universitätsklinikum Köln | Köln | Nordrhein-Westfalen | 50937 | Germany | Details | |
| Universitätsmedizin der Johannes Gutenberg Universität Mainz | Mainz | Rheinland-Pfalz | 55131 | Germany | Details |